Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19

Abstract

RAAS Inhibitors in Patients with Covid-19 The effects of renin–angiotensin–aldosterone system blockers on angiotensin-converting enzyme 2 levels and activity in humans are uncertain. The authors hy...